Bioresponsive polymers for nonviral gene delivery

Current Opinion in Molecular Therapeutics

Volumn 11, Issue 2, 2009, Pages 165-178

  Yu, Haijun ^a   Wagner, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bioresponsive; Covalent conjugate; Gene delivery; PDNA redox sensitive; pH sensitive; SiRNA

Indexed keywords

ACETAL; ANTISENSE OLIGONUCLEOTIDE; ASIALOGLYCOPROTEIN RECEPTOR; MACROGOL; MELITTIN; OLIGONUCLEOTIDE; PLASMID DNA; POLY(4 HYDROXY LEVO PROLINE ESTER); POLY(BETA AMINO ESTER); POLY(LEVO LACTIDE CO LEVO LYSINE); POLY(SERINE ESTER); POLY[ALPHA (4 AMINOBUTYL) LEVO GLYCOLIC ACID]; POLYCATION; POLYESTER; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTISENSE THERAPY; ARTICLE; CELL MIGRATION; CYTOTOXICITY; DISULFIDE BOND; DNA VECTOR; DRUG STRUCTURE; ENDOSOME; GENETIC TRANSFECTION; HUMAN; HYDROLYSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PH; PROTEIN TARGETING;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; HYDROGEN-ION CONCENTRATION; POLYMERS;

EID: 63849199884     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (157)

1. Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature (2004) 431(7006): 371-378.
2. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, John M et al: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature (2004) 432(7014):173-178.
3. Behlke MA: Progress towards in vivo use of siRNAs. Mol Ther (2006) 13(4):644-670.
4. Aigner A: Gene silencing through RNA interference (RNAi) in vivo: Strategies based on the direct application of siRNAs. J Biotechnol (2006) 124(1): 12-25.
5. Meyer M, Wagner E: Recent developments in the application of plasmid DNA-based vectors and small interfering RNA therapeutics for cancer. Hum Gene Ther (2006) 17(ll):1062-1076.
6. Blow N: Small RNAs: Delivering the future. Nature (2007) 450(7172):1117-1120.
7. Bennett CF: Antisense oligonucleotides: Is the glass half full or half empty? Biochem Pharmacol (1998) 55(1):9-19.
8. Pack DW, Hoffman AS, Pun S, Stayton PS: Design and development of polymers for gene delivery. Nat Rev Drug Discov (2005) 4(7):581-593.
9. Dang JM, Leong KW: Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev (2006) 58(4): 487-499.
10. Park TG, Jeong JH, Kim SW; Current status of polymeric gene delivery systems. Adv Drug Deliv Rev (2006) 58(4): 467-486.
11. Wagner E, Kloeckner J: Gene delivery using polymer therapeutics. Adv Polym Sci (2006) 192:135-173.
12. Tiera MJ, Winnik FO, Fernandes JC: Synthetic and natural polycations for gene therapy: State of the art and new perspectives. Curr Gene Ther (2006) 6(1):59-71.
13. Schaffert D, Wagner E: Gene therapy progress and prospects: Synthetic polymer-based systems. Gene Ther (2008) 15(16): 1131-1138.
14. Wagner E: Strategies to improve DNA polyplexes for in vivo gene transfer: Will "artificial viruses" be the answer? Pharm Res (2004) 21(1):8-14.
15. Wagner E: Programmed drug delivery: Nanosystems for tumor targeting. Expert Opin Biol Ther (2007) 7(5):587-593.
16. Wolff JA, Rozema DB: Breaking the bonds: Non-viral vectors become chemically dynamic. Mol Ther (2008) 16(1):8-15.
17. Wagner E, Zatloukal K, Cotten M, Klrlappos H, Mechtler K, Curiel DT, Birnstlel ML: Coupling of adenovirus to transferrin-polylysine/ DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA (1992) 89(13):6099-6103.
18. Plank C, Zatloukal K, Cotten M, Mechtler K, Wagner E; Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug Chem (1992) 3(6): 533-539.
19. Wagner E, Plank C, Zatloukal K, Cotten M, Blrnstiel ML: Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA (1992) 89(17):7934-7938.
20. Murthy N, Campbell J, Fausto N, Hoffman AS, Stayton PS: Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. J Control Release (2003) 89(3):365-374.
21. Rozema DB, Ekena K, Lewis DL, Loornis AG, Wolff JA: Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules. Bioconjug Chem (2003) 14(l):51-57.
22. Griffiths PC, Khayat Z, Tse S, Heenan RK, King SM, Duncan R: Studies on the mechanism of interaction of a bioresponsive endosomolytic polyamidoamine with interfaces, 1, Micelles as model surfaces. Biomacromolecules (2007) 8(3): 1004-1012.
23. Salto G, Swanson JA, Lee KD: Drug delivery strategy utilizing conjugation via reversible disulfide linkages: Role and site of cellular reducing activities. Adv Drug Deliv Rev (2003) 55(2); 199-215.
24. Chen CP, Kim JS, Steenblock E, Liu D, Rice KG: Gene transfer with poly-melittin peptides. Bioconjug Chem (2006) 17(4): 1057-1062.
25. Read ML, Bremner KH, Ouplcky D, Green NK, Searle PF, Seymour LW: Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J Gene Med (2003) 5(3): 232-245.
26. Read ML, Singh S, Ahmed Z, Stevenson M, Brlggs SS, Oupicky D, Barrett LB, Spice R, Kendall M, Berry M, Preece JA et al: A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res (2005) 33(9) :e86.
27. Li SD, Muang L: Non-viral is superior to viral gene delivery. J Control Release (2007) 123(3): 181-183.
28. Hama S, Akita H, Ito R, Mizuguchi H, Hayakawa T, Harashima H: Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol Ther (2006) 13(4): 786-794.
29. Remy JS, Kichler A, Mordvlnov V, Schuber F, Behr JP: Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: A stage toward artificial viruses. Proc Natl Acad Sci USA (1995) 92(5): 1744-1748.
30. Budker V, Gurevich V, Hagstrom JE, Bortzov F, Wolff JA: pH-sensitive, cationic liposomes: A new synthetic virus-like vector. Nat Biotechnol (1996) 14(6): 760-764.
31. Zuber G, Dauty E, Nothlsen M, Belguise P, Behr JP: Towards synthetic viruses. Adv Drug Deliv Rev (2001) 52(3):245-253.
32. Boeckle S, Wagner E: Optimizing targeted gene delivery: Chemical modification of viral vectors and synthesis of artificial virus vector systems. AAPS J (2006) 8(4):E731-E742.
33. de Bruin K, Ruthardt N, von Gersdorff K, Bauslnger R, Wagner E, Ogris M, Brauchle C: Cellular dynamics of EGF receptor-targeted synthetic viruses. Mol Ther (2007) 15(7):1297-1305.
34. Wagner E: Converging paths of viral vector engineering. Mol Ther (2008) 16(1): 1-2.
35. Cotten M, Langle-Rouault F, Kirlappos H, Wagner E, Mechtler K, Zenke M, Beug H, Blrnstiel ML: Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc Natl Acad Sci USA (1990) 87(ll):4033-4037.
36. Wagner E, Zenke M, Cotten M, Beug H, Birnstlel ML: Transferrin- polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA (1990) 87(9):3410-3414.
37. Curiel DT, Agarwal S, Wagner E, Cotten M: Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA (1991) 88(19);8850-8854.
38. Wagner E: Application of membrane-active peptides for nonviral gene delivery. Adv Drug Deliv Rev (1999) 38(3): 279-289.
39. Legendre JY, Trzeciak A, Bohrrnann B, Deuschle U, Kltas E, Supersaxo A: Dioleoylmelittin as a novel serum-insensitive reagent for efficient transfection of mammalian cells. Bioconjug Chem (1997) 8(l):57-63.
40. Ogris M, Carlisle RC, Bettinger T, Seymour LW: Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors. J Biol Chem (2001) 276(50) :4755Q-47555.
41. Shir A, Ogris M, Wagner E, Levltzki A: EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. PLoS Med (2006) 3(l):e6.41
42. Boeckle S, Wagner E, Ogris M: C- versus N-terminally linked melittin-polyethylenimine conjugates: The site of linkage strongly influences activity of DNA polyplexes. J Gene Med (2005) 7(10):1335-1347.
43. Meyer M, Zlntchenko A, Ogris M, Wagner E: A dimethylmaleic acid-melittin-polylysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and enhanced gene transfer potential. J Gene Med (2007) 9(9):797-805.
44. Meyer M, Phillpp A, Oskuee R, Schmidt C, Wagner E: Breathing life into polycations: Functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J Am Chem Soc (2008) 130(ll):3272-3273.
45. Boeckle S, Fahrmeir J, Roedl W, Ogris M, Wagner E: Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexes. J Control Release (2006) 112(2):240-248.
46. Ogris M, Stelnleln P, Kursa M, Mechtler K, Kircheis R, Wagner E: The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther (1998) 5(10):1425-1433.
47. Plank C, Mechtler K, Szoka FC Jr, Wagner E: Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery. Hum Gene Ther (1996) 7(12):1437- 1446.
48. Dash PR, Read ML, Barrett LB, Wolfert MA, Seymour LW: Factors affecting blood clearance and In vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther (1999) 6(4);643-650.
49. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E: PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther (1999) 6(4):595-605.
50. Erbacher P, Bettinger T, Belguise-Valladier P, Zou S, Coll JL, Behr JP, Remy JS: Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med (1999) l(3):210-222.
51. Oupicky D, Ogris M, Howard KA, Dash PR, Ulbrich K, Seymour LW: Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther (2002) 5(4);463-472.
52. Meyer M, Wagner E: pH-responsive shielding of non-viral gene vectors. Expert Opin Drug Deliv (2006) 3(5):563-571.
53. Greenfield RS, Kaneko T, Daues A, Edson MA, Fitzgerald KA, Olech U, Grattan JA, Spitalny GL, Braslawsky GR: Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker. Cancer Res (1990) 50(20);660Q-6607.
54. Shin J, Shurn P, Thompson DH: Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J Control Release (2003) 91(l-2):187-200.
55. Choi JS, MacKay JA, Szoka FC Jr: Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: Preparation and characterization. Bioconjug Chem (2003) 14(2):420-429.
56. Walker GF, Fella C, Pelisek J, Fahrmeir J, Boeckle S, Ogris M, Wagner E: Toward synthetic viruses: Endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol Ther (2005) ll(3):418-425.
57. Fella C, Walker GF, Ogris M, Wagner E: Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding. Eur J Pharm Sci (2008) 34(4-5):309-320.
58. DeRouchey J, Schmidt C, Walker GF, Koch C, Plank C, Wagner E, Radler JO: Monomolecular assembly of siRNA and poly(ethylene glycol)-peptide copolymers. Biomacromolecules (2008) 9(2): 724-732.
59. Murthy N, Campbell J, Fausto N, Hoffman AS, Stayton PS: Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs. Bioconjug Chem (2003) 14(2):412-419.
60. Knorr V, Allmendinger L, Walker GF, Paintner FF, Wagner E: An acetal-based PEGylation reagent for pH-sensitive shielding of DNA polyplexes. Bioconjug Chem (2007) 18(4):1218-1225.
61. Xiong MP, Bae Y, Fukushima S, Forrest ML, Nishiyama N, Kataoka K, Kwon GS: pH-responsive multi-PEGylated dual cationic nanoparticles enable charge modulations for safe gene delivery. ChemMedChem (2007) 2(9): 1321-1327.
62. Takae S, Miyata K, Oba M, Ishii T, Nishiyama N, Itaka K, Yamasaki Y, Koyama H, Kataoka K: PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. J Am Chem Soc (2008) 130(18):6001-6009.
63. Miyata K, Oba M, Kano MR, Fukushima S, Vachutinsky Y, Han M, Koyama H, Mlyazono K, Nishiyama N, Kataoka K: Polyplex micelles from triblock copolymers composed of tandemly aligned segments with biocompatible, endosomal escaping, and DNA-condensing functions for systemic gene delivery to pancreatic tumor tissue. Pharm Res (2008) 25(12):2924-2936.
64. Ward CM, Read ML, Seymour LW: Systemic circulation of poly(L-Iysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: Differential circulation in mice and rats and the implications for human gene therapy. Blood (2001) 97(8):2221-2229.
65. Thomas M, Klibanov AM: Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA (2002) 99(23): 14640-14645.
66. Kloeckner J, Wagner E, Ogris M: Degradable gene carriers based on oligomerized polyamines. Eur J Pharm Sci (2006) 29(5):414-425.
67. Lim Y, Choi YH, Park J: A self-destroying polycationic polymer: Biodegradable poly(4-hydroxy-L-proline ester). J Am Chem Soc (1999) 121(24):5633-5639.
68. Lim YB, Han SO, Kong HU, Lee Y, Park JS, Jeong B, Kim SW: Biodegradable polyester, poly[α-(4-aminobutyl)-L- glycolic acid], as a non-toxic gene carrier. Pharm Res (2000) 17(7): 811-816.
69. Oster CG, Wittrnar M, Unger F, Barbu-Tudoran L, Schaper AK, Kissel T: Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticles. Pharm Res (2004) 21(6):927-931.
70. LI Z, Huang L: Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxy- L-proline). J Control Release (2004) 98(3):437- 446.
71. Lynn DM, Langer R: Degradable poly((β-amino esters): Synthesis, characterization and self-assembly with plasmid DNA, J Am Chem Soc (2000) 122(44): 10761-10768.
72. Lim YB, Kim SM, Suh H, Park JS: Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjug Chem (2002) 13(5):952-957.
73. Kim TI, Seo HJ, Choi JS, Yoon JK, Baek JU, Kim K, Park JS: Synthesis of biodegradable cross-linked poly(β-amino ester) for gene delivery and its modification, inducing enhanced transfection efficiency and stepwise degradation. Bioconjug Chem (2005) 16(5):1140-1148.
74. Zhong Z, Song Y, Engbersen JF, Lok MC, Hennink WE, Feljen J: A versatile family of degradable non-viral gene carriers based on hyperbranched poly(ester amine)s. J Control Release (2005) 109(l-3):317-329.
75. Anderson DG, Lynn DM, Langer R: Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl (2003) 42(27):3153-3158.
76. Green JJ, Shi J, Chiu E, Leshchiner ES, Langer R, Anderson DG: Biodegradable polymeric vectors for gene delivery to human endothelial cells. Bioconjug Chem (2006) 17(5):1162-1169.
77. Akinc A, Lynn DM, Anderson DG, Langer R: Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J Am Chem Soc (2003) 125(18):5316-5323.
78. Zugates GT, Anderson DG, Little SR, Lawhorn IE, Langer R: Synthesis of poly(β-amino ester)s with thiol-reactive side chains for DNA delivery. J Am Chem Soc (2006) 128(39): 12726-12734.
79. Akinc A, Anderson DG, Lynn DM, Langer R: Synthesis of poly(β-amino ester)s optimized for highly effective gene delivery. Bioconjug Chem (2003) 14(5):979-988.
80. Anderson DG, Akinc A, Hossain N, Langer R: Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters). Mol Ther (2005) ll(3):426-434.
81. Zugates GT, Tedford NC, Zumbuehl A, Jhunjhunwala S, Kang CS, Griffith LG, Lauffenburger DA, Langer R, Anderson DG: Gene delivery properties of end-modified poly(β-amino ester)s. Bioconjug Chem (2007) 18(6): 1887-1896.
82. Green JJ, Langer R, Anderson DG: A combinatorial polymer library approach yields insight into nonviral gene delivery. Ace Chem Res (2008):doi:10.1021/ar7002336.
83. Forrest ML, Koerber JT, Pack DW: A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem (2003) 14(5):934-940.
84. Kloeckner J, Bruzzano S, Ogris M, Wagner E: Gene carriers based on hexanediol diacrylate linked oligoethylenimine: Effect of chemical structure of polymer on biological properties. Bioconjug Chem (2006) 17(5): 1339-1345.
85. Ahn CH, Chae SY, Bae YH, Kim SW: Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release (2002) 80(l-3):273- 282.
86. Petersen H, Merdan T, Kunath K, Fischer D, Kissel T: Poly(ethylenimine-co-L-lactamide-co-succinamide): A biodegradable polyethylenimine derivative with an advantageous pH-dependent hydrolytic degradation for gene delivery. Bioconjug Chem (2002) 13(4):812-821.
87. Arote R, Kim TH, Kim YK, Hwang SK, Jiang HL, Song HH, Nah JW, Cho MH, Cho CS: A biodegradable poly(ester amine) based on polycaprolactone and polyethylenimine as a gene carrier. Biomaterials (2007) 28(4):735-744.
88. Yu H, Wang W, Chen X, Deng C, Jing X: Synthesis and characterization of the biodegradable polycaprolactone-graft-chitosan amphiphilic copolymers. Biopolymers (2006) 83(3): 233-242.
89. Russ V, Elfberg H, Thoma C, Kloeckner J, Ogris M, Wagner E; Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and In vivo gene transfer. Gene Ther (2008) 15(1): 18-29.
90. Russ V, Gunther M, Halama A, Ogris M, Wagner E: Oligoethylenimine- grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. J Control Release (2008) 132(2): 131-140.
91. Knorr V, Russ V, Allmendinger L, Ogris M, Wagner E: Acetal linked oligoethylenimines for use as pH-sensltive gene carriers. Bioconjug Chem (2008) 19(8): 1625-1634.
92. Knorr V, Ogris M, Wagner E: An acid sensitive ketal-based polyethylene glycol-ollgoethylenimine copolymer mediates improved transfection efficiency at reduced toxicity. Pharm Res (2008) 25(12):2937-2945.
93. Ko IK, Ziady A, Lu S, Kvvon YJ: Acid-degradable cationic methacrylamide polymerized in the presence of plasmid DNA as tunable non-viral gene carrier. Biomaterials (2008) 29(28):3872-3881.
94. Oupicky D, Diwadkar V: Stimuli-responsive gene delivery vectors. Curr Opin Mol Ther (2003) 5(4): 345-350.
95. McKenzie DL, Kwok KY, Rice KG: A potent new class of reductively activated peptide gene delivery agents. J Biol Chem (2000) 275(14):9970-9977.
96. Oupicky D, Carlisle RC, Seymour LW: Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation In vivo. Gene Ther (2001) 8(9): 713-724.
97. Oupicky D, Parker AL, Seymour LW: Laterally stabilized complexes of DNA with linear reducible polycations: Strategy for triggered intracellular activation of DNA delivery vectors. J Am Chem Soc (2002) 124(1):8-9.
98. Lee Y, Mo H, Koo H, Park JY, Cho MY, Jin GW, Park JS: Visualization of the degradation of a disulfide polymer, linear poly(ethylenimine sulfide), for gene delivery. Bioconjug Chem (2007) 18(1):13-18.
99. Kommareddy S, Amiji M: Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug Chem (2005) 16(6); 1423-1432.
100. Akinc A, Thomas M, Klibanov AM, Langer R: Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med (2005) 7(5): 657-663.
101. Sonawane ND, Szoka FC Jr, Verkrnan AS: Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem (2003) 278(45):44826-44831.
102. Stevenson M, Ramos-Perez V, Singh S, Soliman M, Preece JA, Brlggs SS, Read ML, Seymour LW: Delivery of siRNA mediated by histidine-containing reducible polycations. J Control Release (2008) 130(1) :46-56.
103. Manickam DS, Oupicky D: Multiblock reducible copolypeptides containing histidine-rich and nuclear localization sequences for gene delivery. Bioconjug Chem (2006) 17(6):1395-1403.
104. Rahbek UL, Howard KA, Oupicky D, Manickam DS, Dong M, Nielsen AF, Hansen TB, Besenbacher F, Kjerns J: Intracellular siRNA and precursor miRNA trafficking using bioresponsive copolypeptides. J Gene Med (2008) 10(l):81-93.
105. Gosselin MA, Guo W, Lee RJ: Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem (2001) 12(6): 989-994.
106. Sun YX, Zeng X, Meng QF, Zhang XZ, Cheng SX, Zhuo RX: The influence of RGD addition on the gene transfer characteristics of disulfide-containing polyethyleneimine/DNA complexes. Biomaterials (2008) 29(32):4356-4365.
107. Breunig M, Lungwitz U, Liebl R, Goepferlch A: Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci USA (2007) 104(36):14454-14459.
108. Wang XL, Jensen R, Lu ZR: A novel environment-sensitive biodegradable polydisulfide with protonatable pendants for nucleic acid delivery. J Control Release (2007) 120(3):250-258.
109. Wang XL, Ramusovic S, Nguyen T, Lu ZR: Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery. Bioconjug Chem (2007) 18(6):2169-2177.
110. Lin C, Zhong Z, Lok MC, Jiang X, Hennink WE, Feijen J, Engbersen JF: Novel bioreducible poly(amido aminejs for highly efficient gene delivery. Bioconjug Chem (2007) 18(1): 138-145.
111. Hoon Jeong J, Christensen LV, Yockman JW, Zhong Z, Engbersen JF, Jong Kim W, Feijen J, Wan Kim S: Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials (2007) 28(10): 1912-1917.
112. Lin C, Zhong Z, Lok MC, Jiang X, Hennink WE, Feijen J, Engbersen JF: Random and block copolymers of bioreducible poly(amido amine)s with high- and low-basicity amino groups: Study of DNA condensation and buffer capacity on gene transfection. J Control Release (2007) 123(l):67-75.
113. Lin C, Blaauboer CJ, Timoneda MM, Lok MC, van Steenbergen M, Hennink WE, Zhong Z, Feijen J, Engbersen JF: Bioreducible poly(amido amine)s with oligoamine side chains: Synthesis, characterization, and structural effects on gene delivery. J Control Release (2008) 126(2):166-174.
114. Ooya T, Choi HS, Yamashita A, Yui N, Sugaya Y, Kano A, Maruyama A, Akita H, Ito R, Kogure K, Harashima H: Biocleavable polyrotaxane-plasmid DNA polyplex for enhanced gene delivery. J Am Chem Soc (2006) 128(12):3852-3853.
115. Trubetskoy VS, Budker VG, Hanson LJ, Slattum PM, Wolff JA, Hagstrom JE: Self-assembly of DNA-polymer complexes using template polymerization. Nucleic Acids Res (1998) 26(18):4178-4185.
116. Blessing T, Remy JS, Behr JP: Template oligomerization of DNA-bound cations produces calibrated nanometric particles. J Am Chem Soc (1998) 120(33):8519-8520.
117. Trubetskoy VS, Loomis A, Slattum PM, Hagstrom JE, Budker VG, Wolff JA: Caged DNA does not aggregate in high ionic strength solutions. Bioconjug Chem (1999) 10(4):624-628.
118. Blessing T, Remy JS, Behr JP: Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci USA (1998) 95(4):1427-1431.
119. Ouyang M, Remy JS, Szoka FC J: Controlled template-assisted assembly of plasmid DNA into nanometric particles with high DNA concentration. Bioconjug Chem (2000) 11(1): 104-112.
120. Miyata K, Kakizawa Y, Nlshiyama N, Harada A, Yamasaki Y, Koyama H, Kataoka K: Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J Am Chem Soc (2004) 126(8):2355-2361.
121. Neu M, Germershaus O, Mao S, Volgt KH, Behe M, Kissel T: Crosslinked nanocarrlers based upon poly(ethylene Imine) for systemic plasmid delivery: In vitro characterization and in vivo studies in mice. J Control Release (2007) 118(3):370-380.
122. Ratner BD, Bryant SJ: Biomaterials: Where we have been and where we are going. Annu Rev Biomed Eng (2004) 6:41-75.
123. Lehrman S: Virus treatment questioned after gene therapy death. Nature (1999) 401(6753):517-518.
124. Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res (1986) 46(12 Pt l):6387-6392.
125. Young S, Wong M, Tabata Y, Mikos AG: Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release (2005) 109(l-3):256-274.
126. Fukunaka Y, Iwanaga K, Morinnoto K, Kakemi M, Tabata Y: Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release (2002) 80(1-3):333-343.
127. Yu H, Chen X, Lu T, Sun J, Tian H, Hu J, Wang Y, Zhang P, Jing X: Poly(L-lysine)-graft-chitosan copolymers: Synthesis, characterization, and gene transfection effect. Biomacromolecules (2007) 8(5):1425-1435.
128. Bernkop-Schnurch A, Kast CE, Guggi D: Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: Thiomer/GSH systems. J Control Release (2003) 93(2):95-103.
129. Lee D, Zhang W, Shirley SA, Kong X, Hellermann GR, Lockey RF, Mohapatra SS: Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res (2007) 24(1):157-167.
130. Kast CE, Bernkop-Schnurch A: Thiolated polymers - thiomers: Development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials (2001) 22(17): 2345-2352.
131. Leonetti JP, Degols G, Lebleu B: Biological activity of oligonucleotide-poly(L-lysine) conjugates: Mechanism of cell uptake. Bioconjug Chem (1990) 1(2): 149-153.
132. Degols G, Leonetti JP, Benkirane M, Devaux C, Lebleu B: Poly(BL-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res Dev (1992) 2(4):293-301.
133. Oishi M, Nagasaki Y, Itaka K, Nishlyama N, Kataoka K: Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile (β-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc (2005) 127(6): 1624-1625.
134. Oishi M, Nagatsugl F, Sasaki S, Nagasaki Y, Kataoka K: Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages. Chembiochem (2005) 6(4):718-725.
135. Heredia KL, Nguyen TH, Chang CW, Bulmus V, Davis TP, Maynard HD: Reversible siRNA-polymer conjugates by RAFT polymerization. Chem Commun (Camb) (2008) 28:3245-3247.
136. Mok H, Park JW, Park TG: Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition. Bioconjug Chem (2007) 18(5):1483-1489.
137. Bulmus V, Woodward M, Lin L, Murthy N, Stayton P, Hoffman A: A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J Control Release (2003) 93(2):105-120.
138. Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL, Bertin SL, Reppen TW, Chu Q, Blokhln AV, Hagstrom JE, Wolff JA: Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA (2007) 104(32): 12982-12987.
139. Wakefield DH, Klein JJ, Wolff JA, Rozema DB: Membrane activity and transfection ability of amphipathic polycations as a function of alkyl group size. Bioconjug Chem (2005) 16(5):1204-1208.
140. Wu GY, Wu CH: Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem (1987) 262(10):4429- 4432.
141. Ferkol T, Perales JC, Eckman E, Kaetzel CS, Hanson RW, Davis PB: Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. J Clin Invest (1995) 95(2):493-502.
142. Kursa M, Walker GF, Roessler V, Ogris M, Roedl W, Kircheis R, Wagner E: Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug Chem (2003) 14(1):222-231.
143. Moffatt S, Wiehle S, Crlstlano RJ: A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy. Gene Ther (2006) 13(21): 1512-1523.
144. Pilrollo KF, Zon G, Rait A, Zhou Q, Yu W, Hogrefe R, Chang EH: Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther (2006) 17(1): 117-124.
145. Bartlett DW, Su H, Hlldebrandt IJ, Weber WA, Davis ME: Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA (2007) 104(39): 15549-15554.
146. Rao GA, Tsai R, Roura D, Hughes JA: Evaluation of the transfection property of a peptide ligand for the fibroblast growth factor receptor as part of PEGylated polyethylenimine polyplex. J Drug Target (2008) 16(l):79-89.
147. Wood KC, Azarln SM, Arap W, Pasqualini R, Langer R, Hammond PT: Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide. Bioconjug Chem (2008) 19(2):403-405.
148. Schatzlein AG: Targeting of synthetic gene delivery systems. J Biomed Biotechnol (2003) 2003(2): 149-158.
149. Wagner E, Culmsee C, Boeckle S: Targeting of polyplexes: Toward synthetic virus vector systems. Adv Genet (2005) 53:333-354.
150. Russ V, Wagner E: Cell and tissue targeting of nucleic acids for cancer gene therapy. Pharm Res (2007) 24(6): 1047-1057.
151. Tietze N, Pelisek J, Philipp A, Roedl W, Merdan T, Tarcha P, Ogris M, Wagner E: Induction of apoptosis in murine neuroblastoma by systemic delivery of transferrin-shielded siRNA polyplexes for downregulation of Ran. Oligonucleotides (2008) 18(2): 161-174.
152. Philipp A, Meyer M, Wagner E: Extracellular targeting of synthetic therapeutic nucleic acid formulations. Curr Gene Ther (2008) 8(5):324-334.
153. Heldel JD, Yu Z, Liu JY, Rele SM, Liang Y, Zeidan RK, Kornbrust DJ, Davis ME: Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci USA (2007) 104(14): 5715-5721.
154. Kopatz I, Remy JS, Behr JP: A model for non-viral gene delivery: Through syndecan adhesion molecules and powered by actin. J Gene Med (2004) 6(7): 769-776.
155. Sun J, Wlrtz D, Hanes J: Efficient active transport of gene nanocarriers to the cell nucleus. Proc Natl Acad Sci USA (2003) 100(7):3878-3882.
156. Chen HH, Ho YP, Jiang X, Mao HQ, Wang TH, Leong KW: Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. Mol Ther (2008) 16(2):324-332.
157. Brunner S, Furtbauer E, SauerT, Kursa M, Wagner E: Overcoming the nuclear barrier: Cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol Ther (2002) 5(l):80-86.